What one share of Harvard Bioscience holds
Harvard Bioscience, Inc., a Delaware corporation, is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, drug and therapy discovery, bioproduction and preclinical testing for pharmaceutical and therapy development.
Harvard Bioscience’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $19.64 |
|---|---|
| Profit | −$2.33 |
| Capex (buildings and equipment) | $0.40 |
| Free cash flow | −$0.25 |
| Cash and investments | $1.43 |
| Debt | $8.06 |
| Book value | $1.63 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2009 | $28.64 | $2.42 | — | — | — | $25.38 |
| 2010 | $36.79 | $6.47 | — | — | — | $31.88 |
| 2011 | $36.51 | $1.28 | — | — | — | $33.46 |
| 2012 | $37.32 | $0.80 | — | — | — | $35.47 |
| 2013 | $32.95 | −$0.60 | — | — | — | $29.86 |
| 2014 | $32.69 | $0.71 | — | — | — | $29.32 |
| 2015 | $32.35 | −$5.67 | — | — | — | $22.84 |
| 2016 | $30.55 | −$1.30 | — | — | — | $20.96 |
| 2018 | $33.13 | −$0.80 | $0.27 | $0.52 | — | $22.13 |
| 2019 | $30.72 | −$1.20 | $0.32 | $1.81 | — | $21.39 |
| 2020 | $26.42 | −$2.02 | $0.30 | $2.12 | — | $19.46 |
| 2022 | $27.37 | −$2.30 | $0.38 | −$0.11 | — | $17.16 |
| 2023 | $26.46 | −$0.81 | $0.42 | $2.89 | — | $16.84 |
| 2024 | $21.62 | −$2.85 | $0.61 | −$0.28 | — | $14.37 |
| 2025 | $19.50 | −$12.77 | $0.28 | $1.23 | — | $3.07 |
Common questions about Harvard Bioscience
How much does one share of Harvard Bioscience earn?
Over the last 12 months, Harvard Bioscience lost $2.33 for each share on $19.64 of sales.
Does Harvard Bioscience pay a dividend?
Harvard Bioscience didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Harvard Bioscience’s book value per share?
Harvard Bioscience’s book value is $1.63 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Harvard Bioscience have?
Each share of Harvard Bioscience has $1.43 of cash and investments and $8.06 of debt, as of June 30, 2026.
What is Harvard Bioscience’s free cash flow per share?
−$0.25 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Harvard Bioscience bought back shares?
Harvard Bioscience’s share count rose about 48% from 2009 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.